Literature DB >> 3395461

Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways.

T H Privette1, R L Hornsby, R D Myers.   

Abstract

The effect of the novel anxiolytic, buspirone, administered systemically was determined in Sprague-Dawley rats induced to drink ethyl alcohol chronically by repeated microinjections of 25 ng/microliter tetrahydropapaveroline HBr (THP) into brain-stem monoaminergic pathways. Self-selection of alcohol in concentrations from 3% to 30% was determined for each rat in a free-choice drinking situation with water available as the alternative fluid. After stereotaxic implantation of guide tubes, THP was microinjected repeatedly into striatal lemniscal and preoptic sites which were found to mediate significant increases in alcohol preference. After the baseline level of intake of a single, maximally preferred alcohol concentration was established, each rat was treated with either saline vehicle or buspirone given intramuscularly b.i.d. in doses of 5.0 mg/kg or 20 mg/kg. Overall, the repeated administration of either dose of buspirone produced a significant decrease in the voluntary alcohol intake of the rats as measured by the proportion measure and absolute g of alcohol ingested. However, the alteration in drinking varied from animal to animal with respect to both magnitude and duration of the anxiolytic's effect. The response to buspirone seemed to be dependent in part on the individual site in each animal at which THP had been infused to evoke alcohol intake. Post-mortem histological analysis revealed that buspirone-treated rats reduced alcohol consumption by 83% if THP had been microinjected into substantia nigra; by 60% if given in the nucleus accumbens-preoptic area; and by 34% when injected into the medial lemniscus-zona incerta. These results suggest, therefore, that buspirone can exert a specific effect in attenuating the consumption of alcohol of the rat in a free-choice situation. In relation to the differential actions of the anxiolytic, it is envisaged that on an anatomical basis the antagonism of alcohol drinking may be mediated by a pharmacological alteration of circumscribed pathways associated with dopaminergic or serotonergic neurons.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3395461     DOI: 10.1016/0741-8329(88)90012-2

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  9 in total

Review 1.  5-HT1A partial agonists. What is their future?

Authors:  D A Glitz; R Pohl
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

Review 2.  Role of the serotonergic system in alcohol dependence: from animal models to clinics.

Authors:  Youssef Sari; Verity R Johnson; Jason M Weedman
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

Review 3.  Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  What is in that drink: the biological actions of ethanol, acetaldehyde, and salsolinol.

Authors:  Gerald A Deehan; Mark S Brodie; Zachary A Rodd
Journal:  Curr Top Behav Neurosci       Date:  2013

Review 5.  Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities.

Authors:  M Soyka
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

6.  Effects of buspirone and gepirone on i.v. cocaine self-administration in rhesus monkeys.

Authors:  L H Gold; R L Balster
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Ritanserin and voluntary alcohol intake in rats.

Authors:  T Rammsayer; W H Vogel
Journal:  Integr Physiol Behav Sci       Date:  1994 Oct-Dec

Review 8.  Isoquinolines, beta-carbolines and alcohol drinking: involvement of opioid and dopaminergic mechanisms.

Authors:  R D Myers
Journal:  Experientia       Date:  1989-05-15

9.  Elucidating the biological basis for the reinforcing actions of alcohol in the mesolimbic dopamine system: the role of active metabolites of alcohol.

Authors:  Gerald A Deehan; Sheketha R Hauser; Jessica A Wilden; William A Truitt; Zachary A Rodd
Journal:  Front Behav Neurosci       Date:  2013-08-23       Impact factor: 3.558

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.